R. Falk

Molecular Biology · Circulation · 2004–2016

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom R. Falk trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Selkoe

Papers from R. Falk's perspective

Ordered by how strongly the researchers R. Falk trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. (Blood)
  2. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. (Journal of the American College of Cardiology)
  3. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. (New England Journal of Medicine)
  4. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. (New England Journal of Medicine)
  5. Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains
  6. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. (New England Journal of Medicine)
  7. International uniform response criteria for multiple myeloma (Leukemia)
  8. International staging system for multiple myeloma. (Journal of Clinical Oncology)
  9. Improved survival in multiple myeloma and the impact of novel therapies. (Blood)
  10. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)

Their papers